Blackfin Bio is a biotechnology company committed to developing next-generation gene therapies.

Our mission is to bring hope, healing and life-changing benefits to patients living with rare and other diseases of the Central Nervous System.

We are driven by a shared vision: to accelerate the clinical development of gene therapies into life-changing treatments for patients.

Our pioneering research into gene therapies for neurodegenerative diseases would not exist without the world-leading gene therapeutic translational research that has come before.

If you would like to discover how to support Blackfin Bio as an investor, please see our Investors’ page by following the link below.